Latest filing published 05 Jul 2021 for Elicera Therapeutics AB, €5,128.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Margareth Jorvid: trading record in brief
Margareth Jorvid has filed trades across 2 companies (mainly through Finansinspektionen), most often in Elicera Therapeutics AB (publ) and Elicera Therapeutics AB. Over a trading history stretching from 10 June 2021 to 5 July 2021, the count stands at 3 filings.
The open-market record is one-sided, with 1 purchase worth €5,128 and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants.
The record was last updated on 5 July 2021 with an open-market purchase (€5,128) in Elicera Therapeutics AB. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, MAR article 19 gives managers three business days to notify a trade. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Margareth Jorvid
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,100 shares@ SEK 4.3038.7% of flowAktieISIN SE0015382080FI:csv-0df4436a3b7fad26ede7Canonical exit: 3 Oct 2021 (T+90)
- 6,500 shares@ SEK 8.00100.0% of flowAktieISIN SE0015382080FI:csv-1b6a0771bf1afd6e65e6
- 6,500 shares0OptionISIN SE0015988233FI:csv-ac779178d0f2ada84639
3 of 3 declarations